Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Lookup NU author(s): Giovany Orozco LealORCiD, Nigel Armstrong, Dr Ashleigh KernohanORCiD, Dr Diarmuid CoughlanORCiD, Tomos Robinson, Professor Luke ValeORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Orozco leal G, Armstrong N, Kernohan A, Ahmadu C, Coughlan D, McDermott K, Duffy S, O'Meara S, Robinson T, Vale L, Kleijnen J

Publication type: Article

Publication status: Published

Journal: PharmacoEconomics

Year: 2023

Volume: 41

Issue: 7

Pages: 741-750

Print publication date: 01/07/2023

Online publication date: 23/03/2023

Acceptance date: 23/02/2023

Date deposited: 17/08/2023

ISSN (print): 1170-7690

ISSN (electronic): 1179-2027

Publisher: Adis International Ltd.

URL: https://doi.org/10.1007/s40273-023-01259-6

DOI: 10.1007/s40273-023-01259-6

ePrints DOI: 10.57711/9vsj-sa35

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
NIHR
NIHR135447

Share